| Date | Title | Description |
| 17.09.2026 | Hologic Leads U.S. Adoption as Breast Cancer Diagnostics Market Rises from USD 5,878.0 million in 2025 to USD 12,451.97 million by 2036 at 6.9% CAGR | ROCKVILLE, MD /Sept 17, 2026 – According to Fact.MR estimates, the breast cancer diagnostics market stood at USD 5,878.0 million in 2025. The market is projected to reach USD 6,389.41 million in 2026 and climb to USD 12,451.97 million by 20... |
| 14.09.2026 | Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer | Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Techn... |
| 11.09.2026 | Jury Awards $40 Million to Plaintiff in Bellwether Verdict in Bard Implanted Port Catheter MDL | A federal jury in the District of Arizona returned a unanimous verdict awarding plaintiff Kimberly Divelbliss compensatory damages in the amount of $40 million for her injuries from her Bard implanted port catheter. This was the second bell... |
| 03.09.2026 | ASEAN Rapid Diagnostic Test Market to Reach USD 1.36 Billion by 2030 | The ASEAN Rapid Diagnostic Test Market is valued at an estimated USD 1.08 billion in 2025 and is projected to reach USD 1.36 billion by 2030, registering a CAGR of 4.7% during the forecast period. Market growth is being driven by the rising... |
| 21.08.2026 | Immunoassay Testing Market to Reach USD 47.7 Billion by 2030 | The global Immunoassay testing Market is projected to grow from USD 35.5 billion in 2025 to USD 47.7 billion by 2030, registering a CAGR of 6.1% during the forecast period. Market expansion is being driven by the growing burden of chronic a... |
| 14.07.2026 | Body Fluid Analysis Market to Reach $3.65 Billion by 2031 | The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9% during the forecast period. Market growth is primarily driven by the increasing global incidence of infe... |
| 09.07.2026 | Global In Vitro Diagnostic (IVD) Products Market Share, Growth Drivers, Trends, Overall Sales and Demand Forecast To 2032 | The Global In Vitro Diagnostic (IVD) Products Market is witnessing remarkable growth as healthcare systems worldwide prioritize early disease detection, personalized treatment, and preventive care. In vitro diagnostic products have become a... |
| 07.07.2026 | Molecular Diagnostics Market to Reach $30.74 Billion by 2030 | The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investment... |
| 06.07.2026 | Immunoassay Market to Reach $47.7 Billion by 2030 | The global Immunoassay market is projected to grow from USD 35.5 billion in 2025 to USD 47.7 billion by 2030, at a CAGR of 6.1% during the forecast period. Market growth is primarily driven by the expanding elderly population and the increa... |
| 24.06.2026 | IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine | IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.
Waters Biosciences' technologies, including BD FACSDiscover™ and BD Rhapso... |
| 08.06.2026 | BD Issues Nationwide Recall for Specific Lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL Applicators Due to Microbial Contamination | COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement
Summary
Comp... |
| 01.06.2026 | ClearNote Health Secures $52M to Expand Early Cancer Detection | ClearNote Health secured $52 million in Series D funding. This capital fuels accelerated growth in early cancer detection. The round elevates total funding to $185 million. New President and COO Kevin Keegan joins the leadership. ClearNote ... |
| 27.05.2026 | ClearNote Health: $52 Million Series D Raised To Accelerate Early Cancer Detection Growth | ClearNote Health announced it has secured $52 million in Series D financing and appointed clinical oncology diagnostics veteran Kevin Keegan as president and chief operating officer. The company said the funding and leadership expansion wil... |
| 19.05.2026 | 3 in 4 Compromised Healthcare Devices Expose Patient Records, Flare Report Reveals
Flare’s 2026 Report: A 33% Surge in Healthcare Credential Theft Targets the Medical Intelligence Layer | What You Should Know
The Cyber Threat Surge: In its newly released report, The State of Healthcare Credential Exposure in 2026, Threat Exposure Management leader Flare documented a 33% year-over-year increase in compromised healthcare crede... |
| 23.03.2026 | Philips Proposes New Appointment and Re-Appointments to Its Supervisory Board and CEO Re-Appointment | , a global leader in health technology, announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO.
The Supervisory Board will submit to the A... |
| 09.03.2026 | Minnesota Medical Technologies Secures $20.6M for StaySure U.S. Launch | Minnesota Medical Technologies secured $20.6 million in Series A funding. This capital propels the U.S. commercialization of StaySure, its FDA-cleared device for fecal incontinence. The non-invasive solution offers a discreet alternative to... |
| 06.03.2026 | Minnesota Medical Technologies: $20.6 Million Raised To Commercialize StaySure | Minnesota Medical Technologies announced that it has raised $20.6 million in a Series A preferred equity financing to accelerate the commercialization of its fecal incontinence treatment device, StaySure, in the United States.
The funding r... |
| 03.03.2026 | Campaign360 Returns to Marina Bay Sands, Singapore on 20-21 May 2026 | Asia's Premier Marketing Conference to Inspire 1,000+ Brand Leaders
HONG KONG, March 3, 2026 /PRNewswire/ -- Campaign Asia-Pacific, the region's leading source of marketing intelligence, today announces the return of its flagship event, Cam... |
| 09.02.2026 | Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses | Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors
Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications
Announces formation of four divisions: Waters Analytica... |
| 09.02.2026 | Waters forecasts first-quarter profit below Wall Street estimates, shares slide | Waters forecasts first-quarter profit below Wall Street estimates, shares slide
By ReutersFebruary 9, 20262:47 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Waters logo is seen in this illustr... |
| 05.02.2026 | Bactiguard Holding AB’s year-end report 2025 | Bactiguard Holding AB’s year-end report 2025
Thu, Feb 05, 2026 07:00 CET Report this content
A year of strategic execution concluded with a strong Q4 Fourth quarter 2025 (October – December)
Total revenue amounted to SEK 65.6 (68.3) million... |
| 04.02.2026 | 2026 Best in KLAS Awards: The Full List of Software & Services Winners | What You Should Know
The Report: Today, KLAS Research released its 2026 Best in KLAS reports, and the message from the data is clear: The market rewards vendors that use technology to restore the human connection, not complicate it.
The Dyn... |
| 03.02.2026 | World Regional Anaesthesia and Pain Medicine day Workshop brings the Spotlight on Strengthening Patient Safety Standards | New Delhi, Delhi, India
BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain Medicine (RAPM) Day Workshop. With the objective of reinforcing patient-safety practices in R... |
| 05.01.2026 | Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters | This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product
The FDA i... |
| 29.10.2025 | Sherlock 3CG+ Launched in India; Designed to Improve Accuracy and Efficiency of PICC Line Placement in Cancer Patients | New Delhi, Delhi, India
BD (Becton, Dickinson and Company) India announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai and Kolkata. In current Indian clinical practice, typically for can... |
| 29.10.2025 | Saudi Arabia's Global Health Exhibition 2025 Puts Medtech and AI Innovation in the Spotlight Leaders unveiled how data-driven innovation and space research are shaping healthcare in Saudi Arabia and b... | Being held from October 27-30 in Riyadh, the ongoing Global Health Exhibition (GHE 2025) has so far explored how the future for healthcare transformation is being driven through medical technology, AI innovation, investment and internationa... |
| 21.10.2025 | HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine | Core Clinical & Diagnostic Innovations
Real-World Evidence (RWE) Agent Pilot: Atropos Health, in collaboration with Microsoft, is piloting the Atropos Evidence™ Agent at Stanford Health Care. This expert agent generates patient-specific... |
| 16.10.2025 | Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics | Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics
Thu, Oct 16, 2025 10:26 CET Report this content
The diagnostics company Gradientech today announces a new scientific publication confirming the QuickMIC® system to ... |
| 15.09.2025 | BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets | COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement
Summary
Comp... |
| 06.08.2025 | INSPIRE Initiative Launched by BD to Elevate IV Line Safety and Nursing Excellence Across India | New Delhi, Delhi, India
To elevate IV-line safety and enable nursing excellence, BD (Becton, Dickinson and Company), in collaboration with the Infusion Nurses Society (INS) India, has launched the INSPIRE program— Infusion Nursing Summit fo... |
| 16.07.2025 | Early Alert: Infusion Set Performance Issue from BD | This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as signifi... |
| 15.07.2025 | Bactiguard Holding AB’s interim report second quarter 2025 | Bactiguard Holding AB’s interim report second quarter 2025
Tue, Jul 15, 2025 07:00 CET Report this content
Positive EBITDA momentum carried forward in Q2 Second quarter 2025 (April – June)
Total revenue amounted to SEK 52.1 (60.9) million, ... |
| 15.07.2025 | Waters покупает подразделение бионаук и диагностики Becton за $17,5 млрд | Производитель лабораторного оборудования Waters Corp (WAT.N) сообщил, что приобретёт подразделение бионаук и диагностики, выделенное из структуры поставщика медоборудования Becton Dickinson (BDX.N), в рамках сделки на сумму $17,5 млрд, кото... |
| 14.07.2025 |
Deal-making across Wall Street is ramping up, Jim Cramer says | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said deal-making in the corporate world is starting to heat up, telling investors to expect more action in the coming months.
“You don’t get a wave of deals out of nowhere. You get a ripp... |
| 14.07.2025 | Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing | Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model
Doubles Waters' total addressable market to approximately $40 billion, with 5-7% ann... |
| 13.07.2025 | S&P 500 posts slim gain Monday as traders hope for lower tariffs before Aug. 1 deadline: Live updates | The S&P 500 edged higher on Monday even after President Donald Trump threatened high tariffs on more countries over the weekend. Losses were kept in check as investors bet those duties will eventually be negotiated down and looked ahead... |
| 02.07.2025 | BD India Roadshow Introduces Physicians from Across 7 Cities to Cutting-Edge Atherothrombectomy Technology for Vascular Disease Treatment | New Delhi, Delhi, India
To enable awareness and knowledge-sharing around best practices of atherothrombectomy in the treatment of vascular diseases a multi-city roadshow was organized by BD (Becton, Dickinson, and Company), India for Interv... |
| 02.06.2025 | EU Poised to Curb China’s Access to Medical Device Procurement | - |
| 27.05.2025 | BD Safe Emergency Seminar Launched to Provide Rich Knowledge Sharing Platform for Emergency Department Doctors | New Delhi, Delhi, India
To raise awareness and foster discussions on the safety of healthcare workers (HCWs) in emergency departments, BD (Becton, Dickinson and Company) has recently launched the ’Safe Emergency Seminar’ series across locat... |
| 23.05.2025 | Esophagogastric Tube Recall: BD Issues Correction for Esophagogastric Balloon Tamponade Tubes due to Challenges Removing Plastic Plugs from Rubber Lumen | This recall involves updating the Instructions for using these devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or... |
| 20.05.2025 | The Future of Healthcare: Innovations in Laser Technology and Blood Testing | In the ever-evolving landscape of healthcare, two companies are making waves: Fotona and Babson Diagnostics. Both are pushing boundaries, but in different arenas. Fotona is redefining laser technology, while Babson is revolutionizing blood ... |
| 19.05.2025 | Studies Confirm Capillary Blood Is a Viable Option for Routine Testing | BetterWay blood testing—patient-friendly fingertip collection with accurate lab results
Babson Demonstrates Equivalence Between Capillary Blood and Venous Blood Test Results Using Miniaturized Assays and Novel Collection Methods
AUSTIN, Tex... |
| 15.05.2025 | Fotona® Appoints Jeff Duchemin as Group President and CEO | Duchemin brings global MedTech leadership experience to accelerate Fotona's next phase of growth
DALLAS , May 15, 2025 /PRNewswire/ -- FotonaⓇ, a global leader in high-performing laser systems and energy-based devices for aesthetic, dental ... |
| 06.05.2025 | Expert Risk Tracker Shwetha Mahadevappa Redefines Medical Device Safety | Created by Rico Franco
Updated: May 06 2025, 02:29 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 02.05.2025 | Advancing Healthcare: The New Frontiers of Safety and Technology | In the evolving landscape of healthcare, two significant trends are emerging: a commitment to patient safety and the integration of artificial intelligence (AI). These developments are reshaping how hospitals operate and how patients receiv... |
| 30.04.2025 | 6 More Hospitals in India Commit to Safe Medical Practices by Joining the BD India and JCI PRIME Program | New Delhi, Delhi, India
BD (Becton, Dickinson and Company), a leading global medical technology company in partnership with Joint Commission International, launched their marquee patient and healthcare worker safety program Preventing Risks... |
| 25.04.2025 | ETF Edge
T. Rowe Price sees this established strategy as way to ride out market volatility | It appears T. Rowe Price is benefitting from the record growth in actively managed exchange traded funds.
Tim Coyne, the firm’s head of ETFs, reports the firm is seeing significant growth in the area — listing the T. Rowe Price Capital Appr... |
| 24.04.2025 | Bactiguard Holding AB’s interim report first quarter 2025 | Bactiguard Holding AB’s interim report first quarter 2025
Thu, Apr 24, 2025 07:00 CET Report this content
Continued profitability and revenue growth for Bactiguard First quarter 2025 (January – March)
Total revenue amounted to SEK 62.7 (58.... |
| 18.04.2025 | Early Alert: Intravascular PICC Catheter Issue from BD | This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as signifi... |
| 07.04.2025 | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors
Mon, Apr 07, 2025 08:30 CET Report this content
Stockholm, Sweden, April 7, 2025. Elypta, the Swedish company pioneering metabolism-based early cancer detec... |
| 02.04.2025 | Bridging Knowledge and Innovation in HealthTech: A New Era for Medical Advancements | In the ever-evolving landscape of healthcare, knowledge is the lifeblood that fuels innovation. Recently, BD Life Sciences-Biosciences hosted a pivotal workshop in New Delhi, focusing on Minimal Residual Disease (MRD) assessment in hematolo... |
| 01.04.2025 | BD India Provides Knowledge-sharing Platform for Laboratory Personnel on Minimal Residual Disease | New Delhi, Delhi, India
To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma, BD Life Sciences-Bioscie... |
| 31.03.2025 | “The team must have a clear understanding of the pathway to the market” |
The HealthTech Business Angel of the Year Award recognizes the role Business Angels play in supporting early-stage HealthTech startups. Gido Karges, a Swiss-German Board Member, Consultant, HealhTech investor and Interim Manager with a rem... |
| 20.03.2025 | Update on Alert: Atherectomy Catheter System Issue from Bard Peripheral Vascular | This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. This recall involves updating the Instructions for using these devices and does not involve removing them from where they are used or sold.... |
| 21.02.2025 | Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions | Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it secured $30 million in its Series D financing. The funding round was led by a strategic investor, along with part... |
| 07.02.2025 | The 2025 Best in KLAS Awards: A Beacon of Excellence in Healthcare Technology | The healthcare technology landscape is a vast ocean, teeming with innovation and competition. Each year, the Best in KLAS Awards shine a spotlight on the top performers, guiding healthcare organizations toward the best solutions. The 2025 a... |
| 07.02.2025 | The Pulse of Healthcare Technology: 2025 Best in KLAS Awards Unveiled | The healthcare technology landscape is a bustling marketplace. It’s a realm where innovation meets necessity. The 2025 Best in KLAS Awards shine a spotlight on the leaders in this field. KLAS Research, a trusted name in healthcare IT evalua... |
| 07.02.2025 | The 2025 Best in KLAS Awards: A Spotlight on Healthcare Innovation | The healthcare technology landscape is a bustling marketplace, filled with players vying for recognition. The 2025 Best in KLAS Awards, released by KLAS Research, shines a spotlight on the champions of this arena. These awards are not just ... |
| 07.02.2025 | CSI Companies Shines Bright as 2025 Best in KLAS for Technical Services | In the bustling world of healthcare technology, CSI Companies has emerged as a beacon of excellence. Recently named the 2025 Best in KLAS for Technical Services, this Jacksonville-based firm has proven its mettle in a competitive landscape.... |
| 06.02.2025 | Bactiguard Holding AB’s year-end report 2024 | Bactiguard Holding AB’s year-end report 2024
Thu, Feb 06, 2025 07:00 CET Report this content
License focused strategy delivered increased revenues and profitability Fourth quarter 2024 (October – December)
Total revenue amounted to SEK 68.... |
| 05.02.2025 | In-Depth: 2025 Best in KLAS Overall and Category Awards | What You Should Know:
– KLAS Research, a leading healthcare IT research and consulting firm, has announced the winners of its 2025 Best in KLAS Awards, recognizing the top vendors and service providers in the healthcare technology and servi... |
| 16.01.2025 | Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing Solutions | Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with ... |
| 13.01.2025 | Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions | Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for the clinical and applied markets.
Leader in Next-Generation Sequencing Advances Innovation in Healthcare with Capital and Appointment of ... |
| 09.01.2025 | MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR | – Renowned Experts Beat Müller, Dave Hickey, and David Shulkin Join MeMed’s Advisory Board –
ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)–January 9, 2025–
MeMed, a leader in host-response diagnostics, today announced the addition of t... |
| 24.12.2024 | Knowledge-sharing and Recognizing Excellence in Infusion Therapy through the Mastermind Quiz 2024 | New Delhi, Delhi, India
To promote excellence and innovation in infusion therapy, BD India in association with The Infusion Nurses Society (INS), successfully concluded the BD INS Mastermind Quiz 2024 during the 12th Annual INS National Con... |
| 10.12.2024 | Health | US health panel adds self-testing option for cervical cancer screening | This image provided by BD (Becton, Dickinson and Company) in Dec. 2024 shows the company’s HPV test for cervical cancer screening. (Becton, Dickinson and Company via AP)
Earlier this year, U.S. regulators expanded the use of two HPV test ki... |
| 02.12.2024 | 2024 Medtec Attracts Over 80,000 Industry Attendees, Helping China's Medical Device Sector Step into a New Era of Quality Development | SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- The 2024 Medtec and the 18th International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2024 Medtec), organized by Informa Markets, was successfully held ... |
| 25.10.2024 | Bactiguard's Strategic Shift: A New Era in Infection Prevention | Bactiguard Holding AB is navigating through turbulent waters. The company’s latest interim report for the third quarter of 2024 reveals a significant turnaround. With total revenue soaring to SEK 73.9 million, a 49.4% increase from the prev... |
| 24.10.2024 | Bactiguard Holding AB’s interim report third quarter 2024 | Bactiguard Holding AB’s interim report third quarter 2024
Thu, Oct 24, 2024 07:00 CET Report this content
Bactiguard delivers positive EBITDA and initiates review of 2028 financial targets due to previously announced agreement termination T... |
| 23.10.2024 | BD and College of American Pathologists Celebrate 10 years of Collaboration Dedicated to Laboratory Quality Improvement | New Delhi, Delhi, India
BD, global leader in diagnostic devices, and the CAP (College of American Pathologists), global leader in medical laboratory EQA (External Quality Assessment) and accreditation services, celebrated 10 years of collab... |
| 07.10.2024 | Whatfix Announces USD 58 Million (Rs. 485 Crores) Liquidity Event for its Employees and Investors | Bengaluru, Karnataka, India
Whatfix, a pioneer in the “userization” of application technology, maximizing ROI on enterprise tech stacks, has announced its fourth liquidity program of $58 million. The company facilitated liquidity for employ... |
| 27.09.2024 | Navigating the Crossroads of Innovation and Illicit Trade in India | India stands at a pivotal moment. On one side, the promise of innovation in the medical technology sector shines brightly. On the other, a shadow looms over the economy due to rampant illicit trade. These two narratives are intertwined, sha... |
| 27.09.2024 | Everstone-backed medical devices maker Integris appoints new CEO | Probir Das, group CEO, Integris Health Pvt. Ltd
Integris Health Pvt Ltd, which manufactures and distributes cardiac stents and cardiovascular medical devices under the name Translumina Therapeutics, said Friday it has appointed former chief... |
| 17.09.2024 | Navigating the Complex Landscape of Healthcare Technology: A Dual Focus on User Experience and Patient Safety | In the realm of healthcare, technology is a double-edged sword. On one side, it promises to enhance patient outcomes and streamline workflows. On the other, it poses risks if not designed with care. The challenge lies in balancing user expe... |
| 17.09.2024 | 11 Hospitals Across India Successfully Complete PRIME Program for the 5th Year in a Row | New Delhi, Delhi, India
Preventing risk of infection and medication error in healthcare settings is a key imperative to ensure patient and healthcare worker safety. Aligned with this and given the focus on safe medical practices in hospital... |
| 12.09.2024 | Balancing User Experience and Technical Complexity in Surgical Software Design | Neeraj Mainkar, VP of Software Engineering & Advanced Technology at Proprio
In healthcare, the impact of well-designed medical devices reaches far beyond their physical form. When these devices are thoughtfully crafted with the end-user... |
| 06.09.2024 | Weekly Recap: 10 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate Cancer Awareness Month news and Walk to End Alzheimer's.
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- With thousand... |
| 04.09.2024 |
Edwards Lifesciences starts global layoffs | Edwards Lifesciences (NYSE: EW) + has initiated layoffs across the device developer’s global footprint after completing the $4.2 billion sale of its Critical Care business to Becton, Dickinson and Co.
About 3% of the company’s workforce wil... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 29.08.2024 | The Surge of Cardiac Surgery: A Market in Motion | The global cardiac surgery market is on the rise. It’s a lifeline in a world grappling with cardiovascular diseases (CVDs). These diseases are silent killers, claiming over 17 million lives each year. As technology advances, the market is p... |
| 28.08.2024 | Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research | VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of life-saving interventions, driven by innovations... |
| 08.08.2024 | BD to Present at Wells Fargo 2024 Healthcare Conference | FRANKLIN LAKES, N.J., Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday,... |
| 05.08.2024 | ASP Health Inc. Expands Executive Team with its First National Sales Director | Patrick Moan, National Sales Director, ASP Health
Medical Product Sales and Marketing Veteran Patrick Moan, MBA, to Build Company's Hybrid Sales Force
NORTHBROOK, Ill., Aug. 5, 2024 /PRNewswire-PRWeb/ -- ASP Health Inc., a private medical d... |
| 01.08.2024 | BD Reports Third Quarter Fiscal 2024 Financial Results | Strong Margin Execution Drives Performance in Quarter
Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion, driven by strong organic revenue growth
GAAP and adjusted diluted EPS of $1.68 and $3.50 grew 23.5% and 18.2%, resp... |
| 31.07.2024 | Amsel Medical and Genpact: Navigating New Waters in Healthcare Innovation | In the ever-evolving landscape of healthcare, two companies are making waves: Amsel Medical and Genpact. Each is charting its own course, but both share a common goal: improving patient outcomes through innovative solutions. Amsel Medical r... |
| 30.07.2024 | Amsel Medical Announces Appointment of Chief Executive Officer | CAMBRIDGE, Mass., July 30, 2024 /PRNewswire/ -- Amsel Medical Corporation is pleased to announce the appointment of James A. Heinz, MSL as Chief Executive Officer of Amsel effective July 30, 2024. Mr. Heinz began his service in October 2023... |
| 29.07.2024 | Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company | Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector
NEW YORK, July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm de... |
| 23.07.2024 | BD Board Declares Dividend | FRANKLIN LAKES, N.J., July 23, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per com... |
| 16.07.2024 | Bactiguard Holding AB’s interim report second quarter 2024 | Bactiguard Holding AB’s interim report second quarter 2024
Tue, Jul 16, 2024 07:00 CET Report this content
License revenues and EBITDA stabilizing Second quarter 2024 (April – June) Total revenue amounted to SEK 60.9 (51.2) million, an incr... |
| 03.07.2024 | BD to Announce Financial Results for its Third Quarter of Fiscal 2024 | FRANKLIN LAKES, N.J., July 3, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 ... |
| 20.06.2024 | BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts | FRANKLIN LAKES, N.J., June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the fo... |
| 12.06.2024 | Senior life science and medical specialists join SmartCella’s Board of Directors | Senior life science and medical specialists join SmartCella’s Board of Directors
Wed, Jun 12, 2024 09:00 CET Report this content
SmartCella Holding AB (“SmartCella”) held its 2024 Annual General Meeting on June 10. The company welcomed inve... |
| 09.06.2024 | US’ Memorial Sloan Kettering Cancer Centre builds on India-connect at multiple levels | Close to two years since the United States-based, Memorial Sloan Kettering Cancer Centre, started its facility in Chennai, the 140-year-old organisation, is looking to take the relationship forward at educational, and research levels, inclu... |
| 03.06.2024 | BD Acquires Edwards Lifesciences’ Critical Care Unit for $4.2B to Strengthen Smart Connected Care Portfolio | What You Should Know:
– Becton, Dickinson and Company (BDX: NYSE), a global leader in medical technology, announced today a definitive agreement to acquire Edwards Lifesciences’ (EW: NYSE) Critical Care product group for $4.2 billion in cas... |
| 29.05.2024 | Wockhardt Q4 results: Reports net loss of ₹177 crore; antibiotic products show progress | Drugmaker Wockhardt Limited posted a reduced net loss at ₹177 crore for the three month period ended March 31, 2024, from a net loss of ₹237 crore in the same period last year.
In the current reporting period, the company recognized an impa... |
| 28.05.2024 | BD Partners with Healthians to Increase Access to Cervical Cancer Screening in India | New Delhi, Delhi, India
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced a strategic partnership with Healthians, India’s premier diagnostics service provider, to advance cervical cancer scree... |
| 07.05.2024 | Revolutionizing B2B Communication with AI: Tekst's €700K Funding Boost | Ghent-based Tekst, a cutting-edge AI platform, secures €700K from Entourage to expand its reach in Europe. Founded by ambitious innovators Wouter Janssen and Tiebe Parmentier, Tekst aims to streamline B2B communication through advanced auto... |
| 07.05.2024 | BD Launches the TB Guardianship Program | New Delhi, Delhi, India
To further enhance knowledge exchange amongst healthcare professionals on effective TB diagnostic practices, BD (Becton, Dickinson, and Company), a Corporate TB Pledge holder has recently launched the ‘TB Guardianshi... |
| 06.05.2024 | 2024 Gartner® Voice of the Customer Report Named Whatfix a Customers' Choice for Digital Adoption Platforms | Bangalore, Karnataka, India
Whatfix, the global digital adoption platforms (DAP) leader, has been recognized as a Customers’ Choice in the Gartner report. This distinction placed Whatfix in the top-right section of Peer Insights Quadrant, t... |
| 06.05.2024 | Babson Diagnostics partners with Cynergy to oversee its BetterWay blood test | BetterWay blood testing will launch in Texas later this year before rolling out nationally
Blood testing informs 70% of clinical decision-making, yet it hasn’t changed much in over 70 years: patients still visit a collection service center ... |
